Flanagan W. Michael
CIK 0001841990
Chief Technical OfficerDirector
Filings
21
Latest Mar 2, 2026
Issuers covered
2
Showing
21 of 21
Page 1
Track record
Realized signed returns on open-market buys and sales
No scored trades yet for Flanagan W. Michael. Track record appears once open-market purchases or sales reach the +30 day horizon.
Issuers
Companies where Flanagan W. Michael has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| RNA | Avidity Biosciences, Inc. | 20 | Feb 27, 2026 |
| RNA | Atrium Therapeutics, Inc. | 1 | Mar 2, 2026 |
All filings
21 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|